รศ.ดร.ภญ.นนทญา นาคคำ

Publication

Scopus Author Profile

International Publication

• Wang CW, Chen WT, Chen CB, Chu CY, Chung-Yee Hui R, Lu CW, Chiu TM, Hung SI, Huei HY, Tassaneeyakul W, Choon SE, Nakkam N, Sukasem C, Jan Wu YJ, Chung HY, Lung JH, Chang JS, Lee YS, Chang YC, Yu KH, Teng YC, Lin SH, Lai KC, Hou HH, Wu J, Chi MH, Lee HE, Yu-Wei Lin Y, Lin YJ, Chung WH, Taiwan/Asian Severe Cutaneous Adverse Reaction Consortium. HLA-B alleles confer susceptibility to sulfasalazine-induced severe cutaneous adverse reactions. Journal of allergy and clinical immunology. 2026;.
• Lawanaskol S, Tassaneeyakul W, Sukasem C, Saksit N, Konyoung P, Nakkam N, Amornpinyo W, Rerkpattanapipat T, Klaewsongkram J, Rerknimitr P, Jantararoungtong T, Poolpun D, Chalom K, Tantraworasin A, Patumanond J, Louthrenoo W, Towiwat P. Development of a non-genetic risk prediction model for allopurinol-induced severe cutaneous adverse drug reactions: a multicenter retrospective observational study. Clinical Rheumatology. 2026;45(4):2305-2317.
• Kosanlawit J, Konyoung P, Amornpinyo W, Tassaneeyakul W, Kanjanawart S, Pattanacheewapull O, Purimart D, Nakkam N. Genetic Variants Associated with Non-Steroidal Anti-Inflammatory Drug-Induced Stevens–Johnson Syndrome and Toxic Epidermal Necrolysis. Medical Sciences. 2026;14(1).
• Khaeso K, Chainansamit SO, Kuwatjanakul P, Komvilaisak P, Nakkam N, Suwannaying K, Vannaprasaht S, Dornsena A, Tassaneeyakul W. Genetic Determinants of Hematopoietic Toxicity Risk in Thai Pediatric Patients Undergoing 6-Mercaptopurine Treatment. Clinical and Translational Science. 2026;19(2).
• Jenjirattithigarn N, Nakkam N, Kanjanawart S, Kaewkamson T, Tassaneeyakul W. Impact of CYP1A2 induction on pharmacokinetics of melatonin. Pharmaceutical Sciences Asia. 2026;53(1):37-43.
• Khaeso K, Foocharoen C, Mahakkanukrauh A, Wanitpongpun C, Suwannaroj S, Nakkam N, Vannaprasaht S, Dornsena A, Tassaneeyakul W. Impact of NUDT15 polymorphisms on myelosuppression in Thai patients with autoimmune diseases undergoing azathioprine therapy. Pharmaceutical Sciences Asia. 2026;53(1):11-22.
• Mungkhunthod S, Prommas S, Puangpetch A, Paholpak P, Nakkam N, Sukasem C, Tassaneeyakul W, Vannaprasaht S. Development and Validation of a Rapid LC/MS-MS Method for Measuring Plasma Quetiapine and Norquetiapine in Psychiatric Patients. J Med Assoc Thai 2025 Aug 7;108(Suppl.2):S92-100.
• Wongwien P, Tassaneeyakul W, Kanjanawart S, Areesimpitak T, Nakkam N, Pussadhamma B, Vannaprasaht S. Validation of an HPLC Method for Determining Sildenafil and NDMS Plasma Concentrations in Pulmonary Arterial Hypertension. J Med Assoc Thai 2025;108(Suppl.2):S66-72.
• Mukherjee EM, Gibson A, Krantz MS, Gangula R, Palubinsky AM, Boyd AS, Zwerner JP, Dewan AK, Nakkam N, Konvinse KC, Li Y, Ram R, Chopra A, Phillips EJ. Single-cell immunopathology of recurrent acute generalized exanthematous pustulosis associated with vancomycin. Journal of Allergy and Clinical Immunology: Global. 2025;100426. doi: https://doi.org/10.1016/j.jacig.2025.100426.
• Towiwat P, Lawanaskol S, Tassaneeyakul W, Sukasem C, Saksit N, Nakkam N, Poolpun D, Rerkpattanapipat T, Klaewsongkram J, Rerknimitr P, Louthrenoo W. Development of Non-Genetic Risk Stratification Model of Severe Allopurinol Hypersensitivity (NoG-ALLOH Score): A Multicenter Study in Thailand. Journal of Clinical Rheumatology and Immunology. 2024 Nov; 24(supp01):151-152.
• Attapong J, Kaset C, Nakkam N, Tassaneeyakul W, Wichukchinda N, Chomean S. Dual approaches in pharmacogenetics: Developing PCR-SSP and RT-PCR methods for HLA-B*13:01 screening to prevent dapsone and Co-trimoxazole SCARs. Heliyon. 2024 August 15;1(15):e34977.
• Kategeaw W, Nakkam N, Kiertiburanakul S, Sukasem C, Tassaneeyakul W, Chaiyakunapruk N. Cost-effectiveness analysis of HLA-B*13:01 screening for the prevention of co-trimoxazole-induced severe cutaneous adverse reactions among HIV-infected patients in Thailand. J Med Econ. 2023 Oct 13:1-17. doi: 10.1080/13696998.2023.2270868. Online ahead of print.
• Wattanachai P, Amornpinyo W, Konyoung P, Purimart D, Khunarkornsiri U, Pattanacheewapull O, Tassaneeyakul W, Nakkam N. Association between HLA alleles and beta-lactam antibiotics-related severe cutaneous adverse reactions. Front Pharmacol. 2023 Sep 19;14:1248386. doi: 10.3389/fphar.2023.1248386. eCollection 2023.
• Nakkam N, Saksit N, Konyoung P, Amornpinyo W, Khunarkornsiri U, Purimart D, Pattanacheewapull O, Naewla T, Wattanachai P, Khaeso K, Chumworathayi P, Tassaneeyakul W. Associations of HLA and drug-metabolizing enzyme genes in co-trimoxazole-induced severe cutaneous adverse reactions. Drug Metab Pharmacokinet. 2022 Oct 18;47:100480. doi: 10.1016/j.dmpk.2022.100480. Epub ahead of print. PMID: 36379177.
• Chomean S, Nakkam N, Tassaneeyakul W, Attapong J, Kaset C. Development of label-free electrochemical impedance spectroscopy for the detection of HLA-B*15:02 and HLA-B*15:21 for the prevention of carbamazepine-induced Stevens-Johnson syndrome. Anal Biochem. 2022 Oct 1;658:114931. doi: 10.1016/j.ab.2022.114931. Epub ahead of print. PMID: 36191668.
• Khaeso K, Komvilaisak P, Chainansamit SO, Nakkam N, Suwannaying K, Kuwatjanakul P, Hikino K, Dornsena A, Kanjanawart S, Laoaroon N, Vannaprasaht S, Taketani T, Tassaneeyakul W. NUDT15 is a key genetic factor for prediction of hematotoxicity in pediatric patients who received a standard low dosage regimen of 6-mercaptopurine. Drug Metabolism and Pharmacokinetics. 2022 Apr;43: 100436.
• Nakkam N, Konyoung P, Amornpinyo W, Saksit N, Tiamkao S, Khunarkornsiri U, Khaeso K, Pattanacheewapull O, Jorns TP, Chumworathayi P, Tassaneeyakul W. Genetic variants associated with severe cutaneous adverse reactions induced by carbamazepine. Br J Clin Pharmacol. 2022 Feb;88(2):773-786. doi: 10.1111/bcp.15022. Epub 2021 Aug 28. PMID: 34350628.

National Publication

• Amornpinyo W, Nakkam N, Pattanacheewapull O, Tassaneeyakul W. Epidemiology of Severe Cutaneous Adverse Drug Reactions in a Northeastern Region of Thailand. Srinagarind Med J. 2025 Mar-Apr;40(2):172-185.